Lipedema Academy

Lipedema and insulin resistance: how blood sugar, appetite and weight management are affected

Prof.Dr. Mustafa SAÇAR

Lipedema and insulin resistance are not the same condition, but they can overlap in daily life. Appetite swings, sugar cravings, increasing waist size, difficulty with weight management and tiredness after meals may make the two issues feel connected. Insulin resistance means that body cells respond less effectively to insulin, so blood glucose can fluctuate more easily and the pancreas may need to produce more insulin. Lipedema is a separate clinical condition with painful, symmetrical fat accumulation in the legs and sometimes the arms. Reducing the patient’s story to “weight only” misses the lipedema pattern, while blaming every metabolic symptom on lipedema is also incomplete (Faerber et al., 2024; Jeziorek et al., 2025).

Does insulin resistance cause lipedema?

Current evidence does not show insulin resistance as the single cause of lipedema. Lipedema is discussed as a complex condition involving genetic predisposition, hormonal life stages, adipose tissue biology, microcirculation and inflammation. Insulin resistance may coexist in some patients, especially when abdominal fat, low physical activity, poor sleep, frequent snacking or a high glycemic load are present.

This distinction changes the care plan. Lipedema tissue often does not behave like ordinary excess weight; when pain, tenderness, easy bruising and relatively spared feet are present, lipedema symptoms gives a better clinical frame than the scale alone. If waist circumference, triglycerides, fasting glucose or HbA1c are abnormal, the metabolic side should be assessed separately.

Is insulin resistance more common in people with lipedema?

The answer is more nuanced than many patients expect. Recent studies suggest that women with lipedema may have a more favorable metabolic profile than women with lifestyle-induced obesity at a similar BMI. In a 2025 study by Jeziorek and colleagues, impaired glucose metabolism and insulin resistance were less frequent in the lipedema group than in the overweight/obesity group. Cifarelli and colleagues also reported higher whole-body insulin sensitivity in women with obesity and lipedema compared with women matched for BMI and total adiposity but without lipedema (Cifarelli et al., 2025; Jeziorek et al., 2025).

This does not mean that insulin resistance cannot occur in lipedema. A safer interpretation is that lower-body lipedema fat and abdominal visceral fat may carry different metabolic risks. When abdominal obesity, menopause, inactivity or coexisting obesity become more pronounced, insulin resistance can still develop. lipedema vs obesity therefore matters not only for appearance, but also for understanding where metabolic risk may come from.

How can blood sugar swings affect lipedema symptoms?

Blood sugar variation should not be seen as a simple switch that directly grows lipedema tissue. Still, frequent high-glycemic meals, snacking and insufficient protein can disturb appetite rhythm. Some patients notice more afternoon cravings, post-meal sleepiness or a heavier feeling in the legs after a day of poorly structured meals.

These experiences do not diagnose insulin resistance. They do, however, help explain why symptoms fluctuate from week to week when diet, sleep, stress and reduced movement overlap. Nutrition in lipedema is not meant to erase the condition; it aims to support glucose stability, inflammatory load, bowel regularity and sustainable weight management. In that sense, lipedema nutrition is not a list of prohibitions, but a way to read daily patterns more clearly.

Which symptoms may suggest insulin resistance?

Insulin resistance can be silent. Practical clues include frequent hunger, sugar cravings soon after meals, abdominal fat gain, afternoon sleepiness, difficulty losing weight, high triglycerides, low HDL cholesterol, polycystic ovary syndrome or a family history of type 2 diabetes. Dark, velvety skin changes on the neck, armpits or groin can also be related to insulin resistance in some patients.

These signs do not replace a lipedema evaluation. Lipedema suspicion is built around pain, symmetry, spared feet, easy bruising and disproportion that does not respond normally to diet. lipedema self-test should not be used to diagnose the disease, but it can help patients organize their findings before a medical visit.

Which blood tests and measurements are useful?

No single test explains everything. Depending on the history, a physician may request fasting glucose, HbA1c, fasting insulin, HOMA-IR, lipid profile, liver enzymes, waist circumference, blood pressure and sometimes an oral glucose tolerance test. HbA1c reflects average blood glucose over the previous 2-3 months. HOMA-IR is a calculated estimate of insulin resistance using fasting glucose and fasting insulin. The American Diabetes Association Standards of Care use fasting glucose, HbA1c and oral glucose tolerance testing among the core diagnostic tools for prediabetes and diabetes (American Diabetes Association Professional Practice Committee, 2026).

In a patient with lipedema, these tests do not answer the question “Do I have lipedema?” by themselves. They help define the accompanying metabolic load so that nutrition, exercise, weight goals and referral to internal medicine or endocrinology can be planned more safely. If fatigue, constipation or thyroid disease complicate the picture, lipedema and thyroid problems helps place metabolic assessment in a broader frame.

Does nutrition mean cutting all carbohydrates?

No. There is no single correct model such as “zero carbohydrate” for every person with lipedema. Low-carbohydrate or ketogenic approaches may help some patients with appetite control, pain perception and weight management, but long-term safety, sustainability and patient selection need individual assessment. Current nutrition reviews note that Mediterranean, low-carbohydrate and ketogenic models have been studied in lipedema, while cautioning that no universal nutritional cure has been proven (Atabilen Pınar et al., 2025).

A practical goal is to reduce the glucose load of meals: adequate protein, quality fats such as olive oil, avocado or nuts, fiber-rich vegetables, measured fruit portions, minimally processed carbohydrates and a regular meal rhythm. If carbohydrates are reduced, vegetables, fiber, electrolytes and micronutrients should not be lost. keto and low-carb diet helps separate a low-carbohydrate plan from a ketogenic plan and explains why patient selection matters.

Where does exercise fit in?

Muscle is an active organ in glucose handling. Regular movement can help muscles use glucose and may improve insulin sensitivity. In lipedema, exercise should not mean pushing through pain; it should support the calf muscle pump, protect joints and preserve daily mobility.

Walking, water-based exercise, low-impact resistance work and short movement breaks may be easier to sustain. Exercise will not make lipedema disappear, but complete inactivity can worsen both metabolic health and the feeling of leg heaviness. lipedema exercises should therefore be seen as a safe movement framework, not as a performance challenge.

When are metformin, GLP-1 or GLP-1/GIP drugs considered?

If insulin resistance, prediabetes, type 2 diabetes or coexisting obesity is present, medication decisions require individualized medical evaluation. Metformin, GLP-1 receptor agonists or GLP-1/GIP medications may be considered by a physician in selected metabolic situations. They should not be presented as drugs that directly cure lipedema. Appetite reduction or weight loss does not guarantee that lipedema pain, tissue tenderness or disproportionate fat distribution will disappear.

Side effects, gallbladder history, pancreatitis risk, pregnancy plans, other medications and eating patterns must be reviewed together. Social media often highlights rapid weight-loss stories, but GIP and GLP-1 analogs is a better place to separate promising metabolic effects from the remaining uncertainties in lipedema.

What should the patient take away?

  • Lipedema and insulin resistance are different conditions; one should not be described as the single cause of the other.
  • Some patients with lipedema may have lower metabolic risk than expected, but abdominal fat and coexisting obesity can change that risk.
  • Sugar cravings, sleepiness after meals and frequent hunger can suggest insulin resistance, but blood tests are needed.
  • The goal of nutrition is not punishment; it is a sustainable plan that lowers glucose load.
  • Low-carbohydrate or ketogenic nutrition may help selected patients, but it is not suitable for everyone without supervision.
  • Exercise does not erase lipedema, but it supports muscle glucose use, mobility and circulation.
  • Medication options require personal medical assessment and should not be framed as a guaranteed lipedema solution.

When should you see a doctor?

Internal medicine or endocrinology evaluation is appropriate when fasting glucose or HbA1c is high, waist size is increasing quickly, cravings are intense, polycystic ovary syndrome is present, diabetes runs in the family, blood pressure is high, triglycerides are elevated or fatty liver is suspected. If leg pain, heaviness, easy bruising, varicose veins, evening swelling or ankle changes are also present, vascular and lymphatic factors should be considered separately. In conservative care, manual lymph drainage and compression should be framed as support for heaviness and circulatory load, not as a promise of fat loss.

5/10/2026
5/11/2026
Mustafa SAÇAR
Prof.Dr. Mustafa SAÇARKalp ve Damar Cerrahisi UzmanıÖzel Cerrahi Hastanesi, Denizli, TURKEY

References

  1. Faerber, G., Cornely, M., Daubert, C., Erbacher, G., Fink, J., Hirsch, T., Mendoza, E., Miller, A., Rabe, E., Rapprich, S., Reich-Schupke, S., Stücker, M., & Brenner, E. (2024). S2k guideline lipedema. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 22(9), 1303–1315.doi:10.1111/ddg.15513PMID: 39188170
  2. Cifarelli, V., Smith, GI., Gonzalez-Nieves, S., Samovski, D., Palacios, HH., Yoshino, J., Stein, RI., Fuchs, A., Wright, TF., & Klein, S. (2025). Adipose Tissue Biology and Effect of Weight Loss in Women With Lipedema. Diabetes, 74(3), 308-319.doi:10.2337/db24-0890PMID: 39652636
  3. Jeziorek, M., Wuczyński, M., Sowicz, M., Adaszyńska, A., Szuba, A., & Chachaj, A. (2025). Metabolic Alterations in Women with Lipedema Compared to Women with Lifestyle-Induced Overweight/Obesity. Biomedicines, 13(4).doi:10.3390/biomedicines13040867PMID: 40299449
  4. Atabilen Pınar, B., Çelik, MN., Altıntaş Başar, HB., Ağagündüz, D., & Karaca, OB. (2025). Current Evidence-Based Clinical Nutritional Approaches in Lipedema: A Scoping Review. Nutrition reviews.doi:10.1093/nutrit/nuaf203PMID: 41288228
  5. American Diabetes Association Professional Practice Committee. (2026). 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026. Diabetes Care, 49(Supplement_1), S27–S49.doi:10.2337/dc26-S002PMID: 41358893

Comments (0)

Please log in to comment.

Login
Loading...